IHS Chemical Week

Regions :: India/Pakistan

Meiji to acquire Indian contract manufacturing and generic drugs firm Medreich for $290 million

7:17 AM MDT | June 12, 2014 | Natasha Alperowicz

Meiji Holdings (Tokyo), through its Meiji Seika Pharma subsidiary, has agreed to acquire Bangalore, India based Medreich Ltd. Meiji agreed to pay $290 million for Medreich, which in 2013 reported sales of $157 million and operating income of $24 million. The agreement is with Med Holdings (Weybridge, UK), Nokha Holdings (Bangalore) and V-Sciences Investments (Singapore), the major shareholders in Medreich.   Medreich, established in 1973, has manufacturing facilities in India and is a contract manufacturing organization (CMO) and contract development and...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa